BCAL Diagnostics Limited (BDX.AX)
AUD 0.1
(-1.04%)
AUD 0.1
(-1.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.52 Million | -6.04 Million | -3.21 Million | -1.2 Million | -661.65 Thousand | -525.01 Thousand |
| Net Income | -6.4 Million | -5.06 Million | -3.38 Million | -1.52 Million | -696.36 Thousand | -429.95 Thousand |
| Depreciation & Amortization | 579.78 Thousand | 113.61 Thousand | 20.6 Thousand | - | 7727.00 | 3552.00 |
| Deferred income taxes | - | -225.68 Thousand | -369.58 Thousand | - | -273.02 Thousand | - |
| Stock-based compensation | 573.28 Thousand | 225.68 Thousand | 369.58 Thousand | 176.25 Thousand | 142.04 Thousand | - |
| Change in working capital | 161.53 Thousand | -1.36 Million | -238.57 Thousand | 127.29 Thousand | -115.52 Thousand | -98.67 Thousand |
| Other non-cash items | 562.49 Thousand | 265.45 Thousand | 384.13 Thousand | 63.96 Thousand | 273.49 Thousand | 105.84 Thousand |
| Investing Cash Flow | -1.15 Million | 3.63 Million | -4.02 Million | -3850.00 | -3807.00 | -7472.00 |
| Investments in PPE | -1.15 Million | -362.47 Thousand | -4.02 Million | -3850.00 | -3807.00 | -7472.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -4 Million | - | - | - |
| Sales/Maturities of investments | - | 4 Million | - | - | - | - |
| Other Investing Activities | - | 4 Million | 4 Million | - | - | - |
| Financing Cash Flow | 8.97 Million | 13.23 Thousand | 9.4 Million | 4.2 Million | 805.04 Thousand | 500 Thousand |
| Debt repayment | -256.88 Thousand | -36.76 Thousand | - | - | -300 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -444.83 Thousand | - | -621.79 Thousand | - | - | - |
| Common Stock Issuance | 9.85 Million | 50 Thousand | 10.03 Million | 4.2 Million | 505.03 Thousand | 500 Thousand |
| Other Financing Activities | -178.85 Thousand | -36.76 Thousand | 9.4 Million | 4.2 Million | 505.03 Thousand | 500 Thousand |
| Accounts receivables | 161.53 Thousand | -2.14 Million | -288.83 Thousand | -317.67 Thousand | -144.01 Thousand | -8953.00 |
| Accounts payables | 449.93 Thousand | 777.13 Thousand | 50.26 Thousand | 444.96 Thousand | 28.49 Thousand | -89.72 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | -1.00 | - | - |
| Cash at beginning of period | 3.17 Million | 5.57 Million | 3.4 Million | 416.22 Thousand | 276.64 Thousand | 309.12 Thousand |
| Cash at end of period | 6.47 Million | 3.17 Million | 5.57 Million | 3.4 Million | 416.22 Thousand | 276.64 Thousand |
| Capital Expenditure | -1.15 Million | -362.47 Thousand | -4.02 Million | -3850.00 | -3807.00 | -7472.00 |
| Effect of forex changes on cash | - | - | 1.00 | - | - | - |
| Net cash flow / Change in cash | 3.29 Million | -2.39 Million | 2.16 Million | 2.99 Million | 139.58 Thousand | -32.48 Thousand |
| Free Cash Flow | -5.67 Million | -6.41 Million | -7.24 Million | -1.21 Million | -665.45 Thousand | -532.48 Thousand |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.99 Million | -6.4 Million | -1.99 Million | -2.4 Million | -1.2 Million | -5.06 Million |
| Depreciation & Amortization | 155.24 Thousand | 579.78 Thousand | 155.24 Thousand | 269.3 Thousand | 134.65 Thousand | 113.61 Thousand |
| Deferred income taxes | - | - | - | - | - | -225.68 Thousand |
| Stock-based compensation | 213.55 Thousand | - | 213.55 Thousand | 73.08 Thousand | 73.08 Thousand | 225.68 Thousand |
| Change in working capital | 80.76 Thousand | 611.46 Thousand | 80.76 Thousand | - | - | -1.36 Million |
| Other non-cash items | -271.02 Thousand | 1.23 Million | -271.02 Thousand | 1.78 Million | 552.27 Thousand | 265.45 Thousand |
| Investing Cash Flow | -510.91 Thousand | -1.15 Million | -510.91 Thousand | -129.11 Thousand | -64.56 Thousand | 3.63 Million |
| Investments in PPE | -510.91 Thousand | -1.15 Million | -510.91 Thousand | -129.11 Thousand | -64.56 Thousand | -362.47 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 4 Million |
| Other Investing Activities | - | - | - | - | - | 4 Million |
| Financing Cash Flow | 3.05 Million | 8.97 Million | 3.05 Million | 2.85 Million | 1.42 Million | 13.23 Thousand |
| Debt repayment | -95.07 Thousand | -256.88 Thousand | - | -161.8 Thousand | - | -36.76 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.39 Million | 9.12 Million | - | 2.73 Million | - | 50 Thousand |
| Other Financing Activities | 3.05 Million | 279.69 Thousand | 3.05 Million | 368.29 Thousand | 1.42 Million | -36.76 Thousand |
| Accounts receivables | 80.76 Thousand | 161.53 Thousand | 80.76 Thousand | - | - | -2.14 Million |
| Accounts payables | - | 449.93 Thousand | - | - | - | 777.13 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 5.01 Million | 3.17 Million | - | 3.17 Million | - | 5.57 Million |
| Cash at end of period | 6.47 Million | 6.47 Million | 727.8 Thousand | 5.01 Million | 921.64 Thousand | 3.17 Million |
| Capital Expenditure | -510.91 Thousand | -1.15 Million | -510.91 Thousand | -129.11 Thousand | -64.56 Thousand | -362.47 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.45 Million | 3.29 Million | 727.8 Thousand | 1.84 Million | 921.64 Thousand | -2.39 Million |
| Free Cash Flow | -2.32 Million | -5.67 Million | -2.32 Million | -1.01 Million | -507.81 Thousand | -6.41 Million |
LLOBF
SOTS
CFR
MVES
BHP
0VHI